The occurrence of T2DM due to administration of STZ (50 mg/kg/IP) in normal rats was evaluated by increased level of blood glucose (mg/dl) and % HbA1c, and reduced level of insulin (pg/dl) and C-peptide (pg/dl). The gene discussed is INS; the disease is type 2 diabetes mellitus.